Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Assessing Double-masked Uveitis Treatment

ClinicalTrials.gov ID: NCT01358266

Public ClinicalTrials.gov record NCT01358266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

Study identification

NCT ID
NCT01358266
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Santen Inc.
Industry
Enrollment
592 participants

Conditions and interventions

Interventions

  • DE-109 44 ug Drug
  • DE-109 440 ug Drug
  • DE-109 880 ug Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Aug 31, 2016
Completion
Nov 30, 2016
Last update posted
Jul 15, 2019

2011 – 2016

United States locations

U.S. sites
74
U.S. states
31
U.S. cities
74
Facility City State ZIP Site status
Not listed Phoenix Arizona
Not listed Tucson Arizona
Not listed Beverly Hills California
Not listed Loma Linda California
Not listed Los Angeles California
Not listed Mountain View California
Not listed Sacramento California
Not listed Torrance California
Not listed Aurora Colorado
Not listed Colorado Springs Colorado
Not listed Golden Colorado
Not listed Altamonte Springs Florida
Not listed Jacksonville Florida
Not listed Miami Florida
Not listed Orlando Florida
Not listed Pensacola Florida
Not listed Tampa Florida
Not listed Winter Haven Florida
Not listed Augusta Georgia
Not listed Chicago Illinois
Not listed Oak Park Illinois
Not listed Indianapolis Indiana
Not listed Iowa City Iowa
Not listed Wichita Kansas
Not listed Baltimore Maryland
Not listed Boston Massachusetts
Not listed Cambridge Massachusetts
Not listed Peabody Massachusetts
Not listed Ann Arbor Michigan
Not listed Grand Rapids Michigan
Not listed Jackson Michigan
Not listed Royal Oak Michigan
Not listed Southfield Michigan
Not listed Edina Minnesota
Not listed St Louis Missouri
Not listed Missoula Montana
Not listed Lincoln Nebraska
Not listed Omaha Nebraska
Not listed Portsmouth New Hampshire
Not listed New Brunswick New Jersey
Not listed Newark New Jersey
Not listed Northfield New Jersey
Not listed Teaneck New Jersey
Not listed Toms River New Jersey
Not listed Albany New York
Not listed New York New York
Not listed Orchard Park New York
Not listed Rochester New York
Not listed Slingerlands New York
Not listed Southern Pines North Carolina
Not listed Winston-Salem North Carolina
Not listed Cleveland Ohio
Not listed Eugene Oregon
Not listed Camp Hill Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed Reading Pennsylvania
Not listed West Mifflin Pennsylvania
Not listed Columbia South Carolina
Not listed Ladson South Carolina
Not listed Rapid City South Dakota
Not listed Knoxville Tennessee
Not listed Arlington Texas
Not listed Austin Texas
Not listed Dallas Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed McAllen Texas
Not listed San Antonio Texas
Not listed Salt Lake City Utah
Not listed Burlington Vermont
Not listed Richmond Virginia
Not listed Virginia Beach Virginia
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01358266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01358266 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →